Latest Articles
Endometriosis and hypertriglyceridemia: Why do we care about severity and typology?
While plausible mechanisms exist for an association between endometriosis and hypertriglyceridemia, prior studies have shown inconsistent findings, possibly due to the inability to assess endometriosis severity or subtypes.
Published: Nov. 14, 2025, midnight
Acrivon Therapeutics Advances ACR-368 in Phase 2b Trial for Endometrial Cancer and Prepares for Initial Data on ACR-2316 - Quiver Quantitative
Acrivon Therapeutics Advances ACR-368 in Phase 2b Trial for Endometrial Cancer and Prepares for Initial Data on ACR-2316 Quiver Quantitative
Published: Nov. 13, 2025, 9:25 p.m.
‘A whole-body disease’: Why endometriosis is so difficult to diagnose and treat - YaleNews
‘A whole-body disease’: Why endometriosis is so difficult to diagnose and treat YaleNews
Published: Nov. 13, 2025, 8:01 p.m.
Insufficient Endometrial Biopsy Increases Cancer Risk - European Medical Journal
Insufficient Endometrial Biopsy Increases Cancer Risk European Medical Journal
Published: Nov. 13, 2025, 1:03 p.m.
Promega wins FDA approval as companion diagnostic for Keytruda-Lenvima combo in uterine cancer - Fierce Biotech
Promega wins FDA approval as companion diagnostic for Keytruda-Lenvima combo in uterine cancer Fierce Biotech
Published: Nov. 13, 2025, 9 a.m.
What it’s like living in chronic pain as a woman - bodyandsoul.com.au
What it’s like living in chronic pain as a woman bodyandsoul.com.au
Published: Nov. 13, 2025, 7:18 a.m.
FDA Approves Promega OncoMate® MSI Dx as Companion Diagnostic for KEYTRUDA® and LENVIMA® in Endometrial Cancer - Voice Of HealthCare
FDA Approves Promega OncoMate® MSI Dx as Companion Diagnostic for KEYTRUDA® and LENVIMA® in Endometrial Cancer Voice Of HealthCare
Published: Nov. 13, 2025, 6:17 a.m.
FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma - 뉴스와이어
FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma 뉴스와이어
Published: Nov. 13, 2025, 5:50 a.m.
Absci Corp (ABSI) Q3 2025 Earnings Call Highlights: Strategic Shifts and Strong Cash Position ... By GuruFocus - Investing.com Canada
Absci Corp (ABSI) Q3 2025 Earnings Call Highlights: Strategic Shifts and Strong Cash Position ... By GuruFocus Investing.com Canada
Published: Nov. 13, 2025, 5:35 a.m.
Amy Schumer shares powerful message as she reveals real reason for social media exit - HELLO! Magazine
Amy Schumer shares powerful message as she reveals real reason for social media exit HELLO! Magazine
Published: Nov. 13, 2025, 5:29 a.m.
Link copied to clipboard!